Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

M. Patricia Hidalgo; Carlos A. Celis; Maria Ximena Rojas-Reyes; Rodolfo J. Dennis

doi:10.1002/14651858.CD012100

Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

M. Patricia Hidalgo
, Carlos A. Celis
, Maria Ximena Rojas-Reyes
, Rodolfo J. Dennis

Research output: Contribution to journal › Review article › peer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

Original language	English
Article number	CD012100
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	2
DOIs	https://doi.org/10.1002/14651858.CD012100
State	Published - 29 Feb 2016
Externally published	Yes

Access to Document

10.1002/14651858.CD012100

Cite this

@article{d9bc72ba13ca4340a738105eea18abd0,

title = "Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.",

author = "\{Patricia Hidalgo\}, M. and Celis, \{Carlos A.\} and Rojas-Reyes, \{Maria Ximena\} and Dennis, \{Rodolfo J.\}",

note = "Publisher Copyright: {\textcopyright} 2016 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2016",

month = feb,

day = "29",

doi = "10.1002/14651858.CD012100",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "2",

}

Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD). / Patricia Hidalgo, M.; Celis, Carlos A.; Rojas-Reyes, Maria Ximena et al.
In: Cochrane Database of Systematic Reviews, Vol. 2016, No. 2, CD012100, 29.02.2016.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

AU - Patricia Hidalgo, M.

AU - Celis, Carlos A.

AU - Rojas-Reyes, Maria Ximena

AU - Dennis, Rodolfo J.

PY - 2016/2/29

Y1 - 2016/2/29

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.

UR - https://www.scopus.com/pages/publications/84961960801

U2 - 10.1002/14651858.CD012100

DO - 10.1002/14651858.CD012100

M3 - Review article

AN - SCOPUS:84961960801

SN - 1465-1858

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 2

M1 - CD012100

ER -

Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this